BiondVax Pharmaceuticals Ltd. (BVXV): Price and Financial Metrics
GET POWR RATINGS... FREE!
BVXV Stock Price Chart Interactive Chart >
BVXV Price/Volume Stats
|Current price||$2.43||52-week high||$43.57|
|Prev. close||$2.32||52-week low||$2.10|
|Day high||$2.44||Avg. volume||694,152|
|50-day MA||$2.60||Dividend yield||N/A|
|200-day MA||$3.38||Market Cap||27.59M|
BiondVax Pharmaceuticals Ltd. (BVXV) Company Bio
Biondvax Pharmaceuticals Limited is a pharmaceutical company that develops intra-nasal flu vaccines.
Most Popular Stories View All
BVXV Latest News Stream
|Loading, please wait...|
BVXV Latest Social Stream
View Full BVXV Social Stream
Latest BVXV News From Around the Web
Below are the latest news stories about BiondVax Pharmaceuticals Ltd that investors may wish to consider to help them evaluate BVXV as an investment opportunity.
In this article, we discuss the 10 stocks Cathie Wood is selling. If you want to skip our detailed analysis of these stocks, go directly to Cathie Wood Is Selling These 5 Stocks. There are few institutional investors who are willing to take risks on high growth stocks because of the price volatility and the […]
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today published its second quarter financial results for the quarter ended June 30, 2021.
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV ) Alkermes plc (NASDAQ: ALKS ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Gilead Sciences, Inc. (NASDAQ: GILD ) GlaxoSmithKline plc (NYSE: GSK ) ( announced FDA approval for label expansion for its Jemperli) Novo Nordisk A/S (NYSE: NVO ) Innoviva, Inc. (NASDAQ: INVA ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ) Omega Therapeutics, Inc. (NASDAQ: OMGA ) (IPOed July 30) Pfizer, Inc. (NYSE: PFE ) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) ResMed Inc. (NYSE: RMD ) TScan Therapeutics, Inc. (NASDAQ: TCRX ) Virpax Pharmaceutical...
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today published its first quarter financial results for the quarter ended March 31, 2021. A summary is included in the tables below.
No summary available.
BVXV Price Returns